• CEO Michael Williams reflects on FY26 performance and updates on Roadmap to Win
• Health and safety remain top priority with leading safety performance
• New leadership appointments strengthen the executive team
• FY26 results show strong organic growth in Minerals and Life Sciences
• Lab of the Future initiative drives digital transformation

ALS Limited's CEO Michael Williams addressed shareholders, highlighting FY26 achievements and future strategies. The company prioritized health and safety, achieving a new record low TRIFR of 0.79 and LTIFR of 0.29. Strategic initiatives included the Roadmap to Win, focusing on high-value markets and competitive advantage. Leadership changes saw the appointment of Andrea Vallejo and Rajkumar Mathiravedu, while Michael Williams announced his departure. FY26 results showed strong organic growth in Minerals and Life Sciences, with challenges in the Americas. The Lab of the Future initiative is underway, integrating data, robotics, and AI to enhance productivity and client experience.

FY27 expected high single-digit revenue growth and margin improvement, with Life Sciences contributing more in H2

Positive outlook for FY27 with Minerals ahead of expectations and Life Sciences showing improved organic growth. Hub lab upgrades on track, with potential acceleration in Prague delivery.